Literature DB >> 33038565

Diabetes in late-life schizophrenia: Prevalence, factors, and association with clinical symptoms.

Lijuan Huo1, Xiaobing Lu1, Fengchun Wu1, Xingbing Huang1, Yuping Ning2, Xiang Yang Zhang3.   

Abstract

OBJECTIVE: The prevalence of diabetes mellitus has been found to be higher in patients with schizophrenia. Older patients are the fastest-growing segment of the schizophrenia population. However, few studies have explored diabetes in older patients with schizophrenia. Therefore, this study aimed to determine the prevalence and characteristics of factors associated with diabetes in Chinese patients with late-life schizophrenia (LLS), which has not been reported in previous studies.
METHODS: A total of 289 inpatients aged 60 or above who met the DSM-IV criteria for schizophrenia were recruited. The severity of psychopathology was assessed by the Positive and Negative Syndrome Scale (PANSS). Diabetes was diagnosed by fasting blood glucose tests, or oral glucose tolerance tests.
RESULTS: The overall prevalence of diabetes in LLS patients was 25.3%. The prevalence of diabetes in female patients was significantly higher than that in male patients (35% vs. 21.53%). Other factors associated with diabetes included higher BMI, greater waistline (only for males), higher levels of triglyceride, and more severe positive symptoms.
CONCLUSION: These results indicate that the prevalence of diabetes in LLS patients is similar to that in the age-matched general population. Female gender, excess weight and abdominal obesity, dyslipidemia, and clinical symptoms can be potential risk factors of diabetes in the LLS patient group.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Factors; Late-life schizophrenia; Prevalence

Mesh:

Year:  2020        PMID: 33038565     DOI: 10.1016/j.jpsychires.2020.09.026

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  2 in total

1.  Altered Microstate Dynamics and Spatial Complexity in Late-Life Schizophrenia.

Authors:  Gaohong Lin; Zhangying Wu; Ben Chen; Min Zhang; Qiang Wang; Meiling Liu; Si Zhang; Mingfeng Yang; Yuping Ning; Xiaomei Zhong
Journal:  Front Psychiatry       Date:  2022-06-27       Impact factor: 5.435

2.  Influencing factors of obesity in community patients with deficit schizophrenia: a cross-sectional study.

Authors:  Na Yong; Jiyang Pan; Xuehua Li; Ling Yu; Xin Hou
Journal:  Eur J Med Res       Date:  2022-06-11       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.